Review of biosafety guidelines. Biosafety Task Force, Parenteral Drug Association.
The increased use of recombinant DNA technology, human cell lines, and other human-source materials in the production of pharmaceutical products, has brought to the fore concern for the protection of our employees. A number of guidelines are available that cover "biosafety" issues and are reviewed in this article.
D001709:Biotechnology / Q000592:standards*; D003264:Containment of Biohazards / Q000592:standards*; D014481:United States